AAAAAA

   
Results: 1-9 |
Results: 9
CHARACTERIZATION OF NOVEL ATM GENE-MUTATIONS IN ATAXIA-TELANGIECTASIAFAMILIES
Authors: BENDIX R STOCKMANN C STUHRMANN M OPPITZ D SCHMIDTKE J KARSTENS JH DORK T
Citation: R. Bendix et al., CHARACTERIZATION OF NOVEL ATM GENE-MUTATIONS IN ATAXIA-TELANGIECTASIAFAMILIES, European journal of human genetics, 6, 1998, pp. 4028-4028
MUTATIONS OF THE BRCA1 AND BRCA2 GENES IN GERMAN BREAST-CANCER PATIENTS
Authors: SKAWRAN B BREMER M STUHRMANN M VOLKMANN C SCHMIDTKE J KARSTENS JH DORK T
Citation: B. Skawran et al., MUTATIONS OF THE BRCA1 AND BRCA2 GENES IN GERMAN BREAST-CANCER PATIENTS, European journal of human genetics, 6, 1998, pp. 4029-4029
IS RADICAL PROSTATECTOMY AN APPROPRIATE TREATMENT FOR MEN WITH CLINICAL STAGE CT3 PROSTATE-CANCER
Authors: THON WF STEIN J FROHLICH T KARSTENS JH
Citation: Wf. Thon et al., IS RADICAL PROSTATECTOMY AN APPROPRIATE TREATMENT FOR MEN WITH CLINICAL STAGE CT3 PROSTATE-CANCER, Aktuelle Urologie, 29(5), 1998, pp. 232-236
FREQUENT POLYMORPHISM OF THE GENE MUTATED IN ATAXIA-TELANGIECTASIA
Authors: DORK T WESTERMANN S DITTRICH O TWARDOWSKI M KARSTENS JH SCHMIDTKE J STUHRMANN M
Citation: T. Dork et al., FREQUENT POLYMORPHISM OF THE GENE MUTATED IN ATAXIA-TELANGIECTASIA, Molecular and cellular probes, 11(1), 1997, pp. 71-73
ADJUVANT THERAPY WITH DIBROMODULCITOL AND BCNU INCREASES SURVIVAL OF ADULTS WITH MALIGNANT GLIOMAS
Authors: HILDEBRAND J SAHMOUD T MIGNOLET F BRUCHER JM AFRA D GARFIELD J MCDONALD H PUNT J SOKAL M DETRIBOLET N REGLI L FAVRE J VERNET O DARCELMENAULT F HASSEL MB GUEGAN Y KOCSIS B MAYER A SIPOS L BROTCHI J DEWITTE O REGNIER R CHATEL M FRENAY M HERY M MAAT B HAFERKAMP G KARSTENS JH SAMII M DIETZ H
Citation: J. Hildebrand et al., ADJUVANT THERAPY WITH DIBROMODULCITOL AND BCNU INCREASES SURVIVAL OF ADULTS WITH MALIGNANT GLIOMAS, Neurology, 44(8), 1994, pp. 1479-1483
QUALITY ASSURANCE IN RADIOTHERAPY - MONIT ORING OF THE CORRECT SETTING OF THE RADIOTHERAPEUTIC TARGET VOLUME - RESULTS OF A NATIONAL SURVEYIN GERMANY
Authors: KARSTENS JH BLACH M PLACKE F
Citation: Jh. Karstens et al., QUALITY ASSURANCE IN RADIOTHERAPY - MONIT ORING OF THE CORRECT SETTING OF THE RADIOTHERAPEUTIC TARGET VOLUME - RESULTS OF A NATIONAL SURVEYIN GERMANY, Die medizinische Welt, 45(11), 1994, pp. 457-459
RADIOTHERAPY OF PAINFUL BONE METASTASES - WHAT EFFECT DOES SMALL-FRACTION RADIOTHERAPY HAVE
Authors: BLACH M KARSTENS JH
Citation: M. Blach et Jh. Karstens, RADIOTHERAPY OF PAINFUL BONE METASTASES - WHAT EFFECT DOES SMALL-FRACTION RADIOTHERAPY HAVE, Die medizinische Welt, 45(11), 1994, pp. 460-462
ADJUVANT RADIOTHERAPY IN PATIENTS WITH - STAGE-I SEMINOMA NEW ASPECTS
Authors: KATSOHI D ANDREOPOULOS D GOFFERJE M KARSTENS JH
Citation: D. Katsohi et al., ADJUVANT RADIOTHERAPY IN PATIENTS WITH - STAGE-I SEMINOMA NEW ASPECTS, Die medizinische Welt, 45(11), 1994, pp. 463-466
DETECTION OF SKELETAL INVOLVEMENT IN MALI GNANT DISEASE BY IMMUNOSCINTIGRAPHY OF BONE-MARROW
Authors: RESKE SN KARSTENS JH HENRICH MM SOHN M GLOCKNER W JAKSE G BULL U
Citation: Sn. Reske et al., DETECTION OF SKELETAL INVOLVEMENT IN MALI GNANT DISEASE BY IMMUNOSCINTIGRAPHY OF BONE-MARROW, Nuklearmedizin, 32(3), 1993, pp. 111-119
Risultati: 1-9 |